Trials / Unknown
UnknownNCT04396249
tVNS for Cognitive Impairments in Community-Dwelling Elderly
Transcutaneous Vagus Nerve Stimulation for Cognitive Impairments in Community-Dwelling Elderly
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Shanghai Mental Health Center · Academic / Other
- Sex
- All
- Age
- 65 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to explore the effects of transcutaneous vagus nerve stimulation(tVNS) on improving cognition in community-dwelling elderly people. The study will recruit 120 subjects. Participants will undergo baseline cognitive assessment, EEG and eye tracking. Participants will be randomized to tVNS group and sham group. All subjects will repeat the baseline assessments after 1st session, 5th session,10th session and within 3 days after 10th session.
Detailed description
Transcutaneous vagal nerve stimulation (tVNS) is a non-invasive neurostimulation technology.Recent studies have found that tVNS may involve in the regulation of cognition and improve the memory of the elderly.However, due to the limited number of studies, the effect of tVNS on improving cognitive function and stimulation parameters are currently unclear. To investigate the effects of tVNS on improving cognition in community-dwelling elderly people, our study will recruit 120 subjects. Participants will undergo baseline cognitive assessment, EEG and eye tracking. Active vs. sham treatment will be randomly assigned in a 1:1 fashion in groups using computer generated lists. Subjects and evaluators will be blind to treatment. All subjects will repeat the baseline assessments after 1st session, 5th session,10th session and within 3 days after 10th session.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Active tVNS | One electrode tip is used as their common terminal, and the other two electrode tips are respectively connected to the skin surfaces of the auricle and the external auditory meatus. Each subject will have 10 active tVNS sessions.The active tVNS group will be stimulated with a 2 mA current for 30 minutes. |
| DEVICE | Sham tVNS | Each subject will have 10 sham tVNS sessions.The sham tVNS group will be stimulated with a 2 mA current for 30 minutes. Except for the stimulation site, other parameters are the same as active group. |
Timeline
- Start date
- 2021-05-21
- Primary completion
- 2022-09-30
- Completion
- 2023-08-01
- First posted
- 2020-05-20
- Last updated
- 2022-05-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04396249. Inclusion in this directory is not an endorsement.